Cinarin 15 mg (Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Cinnarizine |
| Company | Nipa pharmaceuticals ltd |
Indications
- Symptomatic treatment of nausea
- Vertigo due to Meniere's disease
- Prevention of motion sickness
- Management of vascular disorders
- Cerebral circulatory disorders
- Peripheral circulatory disorders
- Disorders of balance
Description
Cinarin's actions in the treatment of peripheral vascular disease are due to its anti-vasoconstrictor properties, its action on blood hyperviscosity, and its anti-ischaemic effect.
Pharmacology
Acts as an antihistamine, labyrinthine sedative, and a peripheral antivasoconstrictor. It is a selective calcium antagonist, inhibiting the influx of Ca2+ intracellularly.
Dosage & Administration
Usual adult dose: 15 to 30 mg three times daily. Children (5 to 12 years): Half of the adult dose. Motion sickness: A dose of 30 mg two hours before the start of the journey and 15 mg every 8 hours during the journey. Peripheral arterial diseases: 75 mg two or three times daily.
Interaction
No drug interactions seen with Cinarin when administered concomitantly with antihypertensives, diuretics, anticoagulants, or hypoglycaemics.
Contraindications
No specific contraindications. Reasonable caution in hypotensive patients.
Side Effects
- Somnolence
- Gastrointestinal disturbances
- Allergic skin reactions
- Fatigue
- Extrapyramidal symptoms in elderly people
Pregnancy & Lactation
The safety of Cinnarizine in human pregnancy has not been established although studies in animals have not demonstrated teratogenic effects. Therefore, it is not advisable to administer Cinnarizine in pregnancy
Precautions & Warnings
- Causation of drowsiness
- Avoid driving or operating machinery
- Avoid alcoholic drink
Therapeutic Class
Anti vertigo drugs
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.